Back to search

Article

Validating S100A16 as a prognostic and immunological biomarker in pan-cancer and lung adenocarcinoma through integrated Single-cell Sequencing Analysis

2024-02-28

Abstract excerpt

<h4>Background: </h4> S100A16 belongs to the S100 protein family, exhibiting different expression levels across several human tumors. S100A16 upregulation in many malignancies suggests its potential role in malignant transformation. However, the specific involvement of S100A16 in lung adenocarcinoma (LUAD) remains unclear. Methods This study utilized RNA sequencing and protein expression data from the Cancer Geno...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
daf6b29a-7b5d-5ebb-a1d3-89a63a9c8e26
DOI
10.21203/rs.3.rs-3914587/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Validating S100A16 as a prognostic and immunological biomarker in pan-cancer and lung adenocarcinoma through integrated Single-cell Sequencing AnalysisDOI 10.21203/rs.3.rs-3914587/v1
Select a neighboring publication to make it the new centre.